University of Florida found that, of almost 130million outpatient visits where gabapentin was prescribed, over 99% were for off-label uses – and many patients end up taking it along with drugs that create potentially dangerous interactions.
University of Florida found that, of almost 130million outpatient visits where gabapentin was prescribed, over 99% were for off-label uses – and many patients end up taking it along with drugs that create potentially dangerous interactions.